Search Results - "Patten, Scott M. Van"

Refine Results
  1. 1
  2. 2

    Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease by Van Patten, Scott M, Hughes, Heather, Huff, Michael R, Piepenhagen, Peter A, Waire, James, Qiu, Huawei, Ganesa, Chandrashekar, Reczek, David, Ward, Paul V, Kutzko, Joseph P, Edmunds, Tim

    Published in Glycobiology (Oxford) (01-05-2007)
    “…Recombinant human glucocerebrosidase (imiglucerase, Cerezyme®) is used in enzyme replacement therapy for Gaucher disease. Complex oligosaccharides present on…”
    Get full text
    Journal Article
  3. 3

    Activation of Human Acid Sphingomyelinase through Modification or Deletion of C-terminal Cysteine by Qiu, Huawei, Edmunds, Tim, Baker-Malcolm, Jennifer, Karey, Kenneth P., Estes, Scott, Schwarz, Cordula, Hughes, Heather, Van Patten, Scott M.

    Published in The Journal of biological chemistry (29-08-2003)
    “…One form of Niemann-Pick disease is caused by a deficiency in the enzymatic activity of acid sphingomyelinase. During efforts to develop an enzyme replacement…”
    Get full text
    Journal Article
  4. 4

    Production of recombinant albumin by a herd of cloned transgenic cattle by Echelard, Yann, Williams, Jennifer L, Destrempes, Margaret M, Koster, Julie A, Overton, Susan A, Pollock, Daniel P, Rapiejko, Karen T, Behboodi, Esmail, Masiello, Nicholas C, Gavin, William G, Pommer, Jerry, Van Patten, Scott M, Faber, David C, Cibelli, Jose B, Meade, Harry M

    Published in Transgenic research (01-06-2009)
    “…Purified plasma derived human albumin has been available as a therapeutic product since World War II. However, cost effective recombinant production of albumin…”
    Get full text
    Journal Article
  5. 5

    X-ray and Biochemical Analysis of N370S Mutant Human Acid β-Glucosidase by Wei, Ronnie R., Hughes, Heather, Boucher, Susan, Bird, Julie J., Guziewicz, Nicholas, Van Patten, Scott M., Qiu, Huawei, Pan, Clark Qun, Edmunds, Tim

    Published in The Journal of biological chemistry (07-01-2011)
    “…Gaucher disease is caused by mutations in the enzyme acid β-glucosidase (GCase), the most common of which is the substitution of serine for asparagine at…”
    Get full text
    Journal Article
  6. 6

    Strategies for Neoglycan Conjugation to Human Acid α-Glucosidase by Zhou, Qun, Stefano, James E, Harrahy, John, Finn, Patrick, Avila, Luis, Kyazike, Josephine, Wei, Ronnie, Van Patten, Scott M, Gotschall, Russell, Zheng, Xiaoyang, Zhu, Yunxiang, Edmunds, Tim, Pan, Clark Q

    Published in Bioconjugate chemistry (20-04-2011)
    “…Engineering proteins for selective tissue targeting can improve therapeutic efficacy and reduce undesired side effects. The relatively high dose of recombinant…”
    Get full text
    Journal Article
  7. 7

    Transgenically Produced Human Antithrombin: Structural and Functional Comparison to Human Plasma–Derived Antithrombin by Edmunds, Tim, Van Patten, Scott M., Pollock, Julie, Hanson, Eric, Bernasconi, Richard, Higgins, Elizabeth, Manavalan, Partha, Ziomek, Carol, Meade, Harry, McPherson, John M., Cole, Edward S.

    Published in Blood (15-06-1998)
    “…Recombinant human antithrombin (rhAT) produced in transgenic goat milk was purified to greater than 99%. The specific activity of the rhAT was identical to…”
    Get full text
    Journal Article
  8. 8

    Oxidation of Methionine Residues in Antithrombin by Van Patten, Scott M., Hanson, Eric, Bernasconi, Richard, Zhang, Kate, Manavalan, Partha, Cole, Edward S., McPherson, John M., Edmunds, Tim

    Published in The Journal of biological chemistry (09-04-1999)
    “…Commercially available human plasma-derived preparations of the serine protease inhibitor antithrombin (AT) were shown to contain low levels of oxidation, and…”
    Get full text
    Journal Article
  9. 9

    Strategies for Neoglycan Conjugation to Human Acid [alpha]-Glucosidase by Zhou, Qun, Stefano, James E, Harrahy, John, Finn, Patrick, Avila, Luis, Kyazike, Josephine, Wei, Ronnie, Van Patten, Scott M, Gotschall, Russell, Zheng, Xiaoyang, Zhu, Yunxiang, Edmunds, Tim, Pan, Clark Q

    Published in Bioconjugate chemistry (20-04-2011)
    “…Engineering proteins for selective tissue targeting can improve therapeutic efficacy and reduce undesired side effects. The relatively high dose of recombinant…”
    Get full text
    Journal Article
  10. 10

    Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding by Van Patten, S M, Hanson, E, Bernasconi, R, Zhang, K, Manavalan, P, Cole, E S, McPherson, J M, Edmunds, T

    Published in The Journal of biological chemistry (09-04-1999)
    “…Commercially available human plasma-derived preparations of the serine protease inhibitor antithrombin (AT) were shown to contain low levels of oxidation, and…”
    Get full text
    Journal Article
  11. 11

    Multiplicity of the β Form of the cAMP-dependent Protein Kinase Inhibitor Protein Generated by Post-translational Modification and Alternate Translational Initiation by Priyadarsini Kumar, Scott M. Van Patten, Donal A. Walsh

    Published in The Journal of biological chemistry (08-08-1997)
    “…Two distinct species of the thermostable inhibitor of the cAMP-dependent protein kinase, PKIα and PKIβ, exist that are the products of separate genes. The…”
    Get full text
    Journal Article
  12. 12

    Multiplicity of the β Form of the cAMP-dependent Protein Kinase Inhibitor Protein Generated by Post-translational Modification and Alternate Translational Initiation by Kumar, Priyadarsini, Van Patten, Scott M., Walsh, Donal A.

    Published in The Journal of biological chemistry (08-08-1997)
    “…Two distinct species of the thermostable inhibitor of the cAMP-dependent protein kinase, PKIα and PKIβ, exist that are the products of separate genes. The PKIβ…”
    Get full text
    Journal Article
  13. 13

    The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression by Van Patten, S M, Howard, P, Walsh, D A, Maurer, R A

    Published in Molecular endocrinology (Baltimore, Md.) (01-12-1992)
    “…The inhibitor protein (PKI) of the cAMP-dependent protein kinase was first characterized from rabbit skeletal muscle. More recently a form of PKI was isolated…”
    Get more information
    Journal Article
  14. 14

    Specific Testicular Cellular Localization and Hormonal Regulation of the PKIα and PKIβ Isoforms of the Inhibitor Protein of the cAMP-dependent Protein Kinase by Scott M. Van Patten, Lucy F. Donaldson, Michael P. McGuinness, Priyadarsini Kumar, Azita Alizadeh, Michael D. Griswold, Donal A. Walsh

    Published in The Journal of biological chemistry (08-08-1997)
    “…We have previously demonstrated that there exist two distinct genes for the thermostable inhibitor protein of the cAMP-dependent protein kinase, PKIα and…”
    Get full text
    Journal Article
  15. 15

    Transgenically Produced Human Antithrombin: Structural and Functional Comparison to Human Plasma–Derived Antithrombin by Edmunds, Tim, Van Patten, Scott M., Pollock, Julie, Hanson, Eric, Bernasconi, Richard, Higgins, Elizabeth, Manavalan, Partha, Ziomek, Carol, Meade, Harry, McPherson, John M., Cole, Edward S.

    Published in Blood (15-06-1998)
    “…Recombinant human antithrombin (rhAT) produced in transgenic goat milk was purified to greater than 99%. The specific activity of the rhAT was identical to…”
    Get full text
    Journal Article
  16. 16

    Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase by Toner-Webb, J, van Patten, S M, Walsh, D A, Taylor, S S

    Published in The Journal of biological chemistry (15-12-1992)
    “…The catalytic subunit of cAMP-dependent protein kinase contains two stable phosphorylation sites, Thr-197 and Ser-338 (Shoji, S., Titani, K., Demaille, J. G.,…”
    Get full text
    Journal Article
  17. 17

    Specific Testicular Cellular Localization and Hormonal Regulation of the PKIα and PKIβ Isoforms of the Inhibitor Protein of the cAMP-dependent Protein Kinase by Van Patten, Scott M., Donaldson, Lucy F., McGuinness, Michael P., Kumar, Priyadarsini, Alizadeh, Azita, Griswold, Michael D., Walsh, Donal A.

    Published in The Journal of biological chemistry (08-08-1997)
    “…We have previously demonstrated that there exist two distinct genes for the thermostable inhibitor protein of the cAMP-dependent protein kinase, PKIα and PKIβ…”
    Get full text
    Journal Article
  18. 18

    Molecular Cloning of a Rat Testis form of the Inhibitor Protein of cAMP- Dependent Protein Kinase by Van Patten, Scott M., Ng, Dean C., John P. H. Th'ng, Angelos, Karen L., Smith, Alan J., Walsh, Donal A.

    “…The form of inhibitor protein of the cAMP-dependent protein kinase (PKI) that has been most thoroughly studied is a protein purified from rabbit skeletal…”
    Get full text
    Journal Article
  19. 19

    Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase by THOMAS, J, VAN PATTEN, S. M, HOWARD, P, DAY, K. H, MITCHELL, R. D, SOSNICK, T, TREWHELLA, J, WALSH, D. A, MAURER, R. A

    Published in The Journal of biological chemistry (15-06-1991)
    “…Pure heat-stable inhibitor of the cAMP-dependent protein kinase (PKI) has been isolated in high yield by using a bacterial expression vector constructed to…”
    Get full text
    Journal Article
  20. 20